Skip to main content
Caplight Logo









KNT Investment

KNT Investment

Seoulkntinvestment.com

Overview

KNT Investment is a South Korean cross-border private equity firm that invests in high-potential technology and biotechnology companies across South Korea, Southeast Asia, and North America.

Year Founded

2020

Portfolio Companies

1

Investments

KNT Investment investments
CompanyDateStageLead
CerecinOct 2022Series B ExtensionLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is KNT Investment based?

KNT Investment is headquartered in Seoul, South Korea.

When was KNT Investment founded?

KNT Investment was founded in 2020.

How many portfolio companies does KNT Investment have?

KNT Investment has 1 portfolio company in Caplight's dataset.

What are some companies in KNT Investment's portfolio?

Portfolio companies visible on Caplight include Cerecin.

What was KNT Investment's most recent investment shown here?

KNT Investment's most recent investment in this portfolio sample was in Cerecin in 2022.

What sectors does KNT Investment focus on?

KNT Investment focuses on Healthcare & Life Sciences.

What company stages does KNT Investment focus on?

KNT Investment typically invests at the Early stage.

Firmographic Details

HeadquartersSeoul
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?